Company
Every investor coverage indicates participated in a round Control Bionics Limited raised.
Companies Control Bionics Limited acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Control Bionics Limited. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Australian neurotech company Control Bionics launched a A$10 million capital raising, with a A$9.5 million placement and shareholder plan, backed by existing shareholders Nightingale Partners and Phoenix Development Fund.
Nightingale Partners revisits Control Bionics, which it backed in 2005 and still holds a stake in, marking the assistive-tech firm's December 2020 ASX debut and sharing a chief executive interview.